Targeting misfolding and aggregation of the amyloid-β peptide and mutant p53 protein using multifunctional molecules

We highlight recent advances in the development of multifunctional molecules designed to limit misfolding and aggregation of intrinsically disordered biomolecules, with a focus on the amyloid-beta peptide in AD and the mutant p53 protein in cancer.